Asia Pacific Mass Spectrometry Market

The Asia Pacific mass spectrometry market is projected to reach USD 2.34 billion by 2031 from USD 1.41 billion in 2025, registering a CAGR of 8.9% from 2025 to 2031.

Sustained policy support by the Chinese and Indian governments to boost drug development, genomics, and industrial manufacturing base, along with expanding pharmaceutical and biotechnology R&D outsourcing, is propelling the Asia Pacific mass spectrometry market growth. The increasing focus on biopharma manufacturing, biosimilars, and advanced therapies is further driving the adoption of high-resolution MS systems for protein profiling, impurity analysis, and molecular characterization. In addition, the region’s growing network of CROs and CDMOs, coupled with the emergence of multi-omics research centers and university spin-offs, is reshaping analytical workflows toward data-driven, automated mass spectrometry platforms. Countries such as China, India, Japan, and South Korea are at the forefront of this transformation, emphasizing local instrument manufacturing, workforce training, and collaborative R&D programs with global OEMs.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific, Inc. (US)

Thermo Fisher Scientific is a global leader offering a diversified portfolio of laboratory instrumentation and services across analytical instruments, life sciences solutions, specialty diagnostics, and laboratory products. Its Analytical Instruments segment is a key growth driver, providing a wide range of mass spectrometry platforms tailored for biopharmaceutical, clinical, and research applications.

Thermo Fisher’s MS portfolio spans from triple quadrupole to Orbitrap systems, designed for high accuracy, sensitivity, and throughput. The company is continuously enhancing its AI-driven quantitation tools, workflow automation, and connectivity with chromatography and sample prep systems to deliver seamless analytical experiences. In the Asia Pacific region, Thermo Fisher has been expanding its local manufacturing and service infrastructure, enabling faster deployment, technical support, and application training for regional customers.

Agilent Technologies, Inc. (US)

Agilent Technologies offers a comprehensive suite of LC-MS, GC-MS, and ICP-MS systems, serving a broad spectrum of analytical applications. With a strong presence across North America, Europe, and Asia Pacific, Agilent continues to prioritize R&D investment to sustain innovation and market leadership. The company channels a significant portion of its revenue into developing high-performance hybrid MS systems, automation-ready platforms, and AI-enabled data interpretation tools.
Agilent’s strategy also emphasizes collaborations, acquisitions, and academic partnerships to enhance its application base in life sciences, food safety, environmental testing, and clinical research. In the Asia Pacific region, the company is strengthening its footprint through regional demo labs, training centers, and joint innovation hubs to cater to the growing demand for MS-based solutions.

Waters Corporation (US)

Waters Corporation remains a prominent player in liquid chromatography–mass spectrometry (LC-MS) and thermal analysis systems, serving a global base of research, pharma, and industrial customers. Its mass spectrometry portfolio includes Quadrupole, Xevo TQ, and SYNAPT XS systems for applications spanning trace analysis, complex mixture characterization, and high-resolution accurate mass measurement.

The company’s focus on innovation, usability, and data reproducibility has positioned it as a trusted brand in regulated environments. Waters continues to strengthen its Asia Pacific presence through application labs, distributor partnerships, and customer education programs, aligning its portfolio with regional priorities in clinical proteomics, metabolomics, and pharmaceutical quality testing.

Related Reports:

Asia Pacific Mass Spectrometry Market by Component (Detector, Mass analyzer, Ion source, vacuum system), Product [Triple Quad, Q-TOF, Quad, TOF], Application (Omics, Clinical, Environment, Pharma), Installed Base & replacement rate Forecasts to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com